1191250-53-9

Basic information

• Product Name: tert-butyl 4-(3-[(2,2-dimethylpropanoyl)oxy]benzylidene)-3-methylpiperidine-1-carboxylate
• Synonyms: tert-butyl 4-(3-[(2,2-dimethylpropanoyl)oxy]benzylidene)-3-methylpiperidine-1-carboxylate
• CAS NO: 1191250-53-9
• Molecular Weight: 387.519
• Mol File: 1191250-53-9.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: tert-butyl 4-(3-[(2,2-dimethylpropanoyl)oxy]benzylidene)-3-methylpiperidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 4-(3-[(2,2-dimethylpropanoyl)oxy]benzylidene)-3-methylpiperidine-1-carboxylate(1191250-53-9)
• EPA Substance Registry System: tert-butyl 4-(3-[(2,2-dimethylpropanoyl)oxy]benzylidene)-3-methylpiperidine-1-carboxylate(1191250-53-9)

Safety Data

• Hazardous Substances Data: 1191250-53-9(Hazardous Substances Data)

Upstream product

• 134518-89-1 3-pivaloyloxybenzaldehyde 
• 100-83-4 meta-hydroxybenzaldehyde 
• 3282-30-2 pivaloyl chloride 
• 1190843-65-2 3-(hydroxymethyl)phenyl pivalate 
• 181269-69-2 tert-butyl 3-methyl-4-oxopiperidine-1-carboxylate 
• 1190843-66-3 3-[(diethoxyphosphoryl)methyl]phenyl pivalate 

Downstream Products

• 1190843-58-3 tert-butyl 4-(3-hydroxybenzylidene)-3-methylpiperidine-1-carboxylate 
• 1191286-55-1 (3S,4E)-3-methyl-N-pyridin-3-yl-4-(3-{[5-(trifluoromethyl)pyrimidin-2-yl]oxy}benzylidene)piperidine-1-carboxamide 
• 1191286-54-0 (3R,4E)-3-methyl-N-pyridin-3-yl-4-(3-{[5-(trifluoromethyl)pyrimidin-2-yl]oxy}benzylidene)piperidine-1-carboxamide 
• 1191250-54-0 2-{3-[3-methylpiperidin-4-ylidenemethyl]phenoxy}-5-(trifluoromethyl)pyrimidine 

Relevant articles and documents

ETHER BENZYLIDENE PIPERIDINE ARYL CARBOXAMIDE COMPOUNDS USEFUL AS FAAH INHIBITORS

The present invention relates to compounds of Formula (I) wherein Ar is optionally substituted phenyl or 6-membered heteroaryl moiety, or a benzisoxazole, pyrrolopyridine, or benzotriazole group; or a pharmaceutically acceptable salt thereof; processes for the preparation of the compounds; intermediates used in the preparation of the compounds; compositions containing the compounds; and uses of the compounds in treating diseases or conditions associated with fatty acid amide hydrolase (FAAH) activity, including pain, urinary incontinence, overactive bladder, emesis, cognitive disorders, anxiety, depression, sleeping disorders, eating disorders, movement disorders, glaucoma, psoriasis, multiple sclerosis, cerebrovascular disorders, brain injury, gastrointestinal disorders, hypertension, or cardiovascular disease.

4- [3- (ARYLOXY) BENZYLIDENE] -3-METHYL PIPERIDINE ARYL CARBOXAMIDE COMPOUNDS USEFUL AS FAAH INHIBITORS

The present invention relates to compounds of Formula (I), wherein Ar is optionally substituted phenyl or heteroaryl and X, Y and Z are independently N or CH; or a pharmaceutically acceptable salt thereof; processes for the preparation of the compounds; intermediates used in the preparation of the compounds; compositions containing the compounds; and uses of the compounds in treating diseases or conditions associated with fatty acid amide hydrolase (FAAH) activity.